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Abstract
Background: Herbal medicines played a major role in the treatment of hepatic disorders, and a number of medicinal plants and their compounds
were widely used for the treatment of these disorders, and oxidant stress injury was one of the mechanism of liver injury.
Materials and Methods: Antioxidant activity of Nelumbo nucifera leaves (NU) extracts was assayed by the methods of scavenging
1,1-diphenyl-2-picrylhydrazyl (DPPH), 2,2´-azino-bis (3-ethylbenzo- thiazoline-6-sulfonicacid) (ABTS) radical and ferric reducing antioxidant
power (FRAP) in vitro. By intraperitoneal injection carbon tetrachloride (CCl4) to establish acute liver injury model in mice, the levels of
Glutamic-pyruvic transaminase (GPT), glutamic-oxaloacetic transaminase (GOT), superoxide dismutase (SOD) and the content of and
maleicdialdehyde (MDA) were detected to evaluate hepatoprotective effect of NU using corresponding test kit.
Results: EtOAC (NUEA) and n-BuOH extracts (NUBU) of N. nucifera leaves had good scavenging DPPH and ABTS radical activity and ferric
reducing antioxidant power in vitro. DPPH radical scavenging activity and ferric reducing antioxidant power of NUEA (IC50= 6.68±0.29 µg/mL,
RACT50=1749.82±67.03 µmol/g) and NUBU (IC50= 4.61±0.01 µg/mL, RACT50=1995.27±135.71 µmol/g ) were higher than that of BHT
(IC50=8.76±0.20 µg/mL, RACT50=1581.68±97.41 µmol/g) and Dangfeiliganning (IC50=28.06±0.17 µg/mL, RACT50=1028.55±3.28 µmol/g).
ABTS radical scavenging activity of NUEA (IC50= 5.32±0.12 µg/mL) and NUBU (IC50= 8.16±0.27 µg/mL) were higher than that of
Dangfeiliganning (IC50= 9.76±0.16 µg/mL). Thus, hepatoprotective effect of NUEA and NUBU was evaluated on CCl4-induced acute liver injury
mice. The results showed that the levels of GOT and GPT in each treatment group significantly decreased (p<0.001 and p<0.01, p<0.05,
respectively) except for the group of NUEA (130.8 mg/kg) (p>0.05). The contents of malondialdehyde (MDA) in liver in groups of NUEA (523
mg/kg), NUBU (840.5 and 420.5 mg/kg, repectively) had significant decrease (p<0.001 and p<0.05, respectively), and the level of SOD in liver
for each treatment group could significantly decrease (p<0.001, p<0.05, respectively).
Conclusion: NUEA and NUBU had signiﬁcantly hepatoprotective effect for Calcium tetrachloride CCl4-induced liver injury, which might be
attributable to its antioxidant activity.
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Introduction
Liver injury can be induced by various factors, such as CCl4, ethanol and acetaminophen, which are metabolized by Cytochrome P450
2E1 (CYP2E1) to generate unstable free radicals and reactive oxygen species (ROS), these free radicals and ROS can induce liver cell apoptosis
and necrosis (Sun et al., 2001; Kuzu et al., 2007), and up-regulation of tumor necrosis factor-alpha (TNF-α), interleukin-10 (IL-10) and
transforming growth factor-β (TGF-β) in necrotic hepatocytes that accelerate the progression of liver cell injury.
Carbon tetrachloride (CCl4) is one of the oldest and most widely used toxins for experimental induction of liver injury in laboratory
animals. At present, the mechanism of CCl4-induced liver injury is accepted widely, CCl4 is metabolized to a highly reactive trichloromethyl free
radical (CCl3-) and chlorine free radical (Cl-) by cytochrome P450 in liver microsome. These free radicals may be to bind to macromolecular in
liver cells covalently, and also attack saturated lipids, which can induce lipid peroxidation and lead to hepatocellular membrane damage (Koch et
al., 1974). Herbal medicines play a major role in the treatment of hepatic disorders. A number of medicinal plants and their compounds are widely
used for the treatment of these disorders (Park et al., 2000; Gong et al., 2012; Wei et al., 2012; Praveen et al., 2009;). Berberine is an isoquinoline
alkaloid of the protoberberine type and silymarin is an antioxidant flavonoid complex, derived from the herb used for treatment of hepatic
disorders (Domitrovi´c et al., 2011).
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Nelumbo nucifera leaves (NU) is a well known Chinese herbal medicine. It distributed throughout china, and all parts of N. nucifera
have been used as foodstuffs and Chinese traditional medicines. Moreover, many biological and pharmacological studies have been performed on
each part of the plant. Phytochemical researches have shown that flavonoids and alkaloids were the main active components of N. nucifera leaves,
for example astragalin, queretin, hyperin, armepavine and coclaurine (Yang et al., 2007; Xiao et al., 2006).
Pharmacological studies have shown that N. nucifera leaves had the effects of antioxidant (Deng et al., 2006), anti-HIV (Kawanishi et
al., 2003), antilipemic (Guan et al., 2003), antiobesity (Ono et al., 2006), antibacterium (Li et al., 2003), antigall-stone (Ding et al., 2007),
antilipase (Zhu et al., 2007) and antipoliovirus (Boustie et al., 1998).
In this study, antioxidant activity of N. nucifera leaves extracts was assayed by methods of DPPH, ABTS and FRAP. By intraperitoneal
injection CCl4 to establish acute liver injury model in mice, the levels of GOT, GPT, SOD and the content of MDA were detected to evaluate
hepatoprotective effect of NU.
Materials and methods
Chemicals and Materials
Glutamic-pyruvic transaminase (GPT), glutamic-oxaloacetic transaminase (GOT), maleicdialdehyde (MDA) and superoxide dismutase
(SOD) detection kits were obtained from Jiancheng Institute of Biological Engineering, Nanjing. Dangfeiliganning capsule was obtained from
Sichuan Meidakang Pharmaceutical Co. Ltd. (Batch No: 20080302). Coomassie brilliant blue G-250 was obtained from Shanghai Packing Plant
of Chemical Reagent Co. (Batch No: 20050115). DPPH was obtained from Tokyo, Japan Chemical Industry Co., Ltd. (Japan). TPTZ was from
Acros organics (Belgium). Trolox was obtained from Aldrich (USA). ABTS was obtained from Fluka (USA). Gallic acid propyl (PG),
butyl-p-hydroxyanisole (BHA), butylated hydroxytoluene (BHT) and were purchased from Sigma Chemical Co. CCl4 (AR) were purchased from
Kaifeng chemical reagent factory. All the other organic solvents and chemicals used were analytical grade.
Animals
Male Kunming normal mice weighing 20 ± 2 g were obtained from the Experimental Animal Center of Henan Province. (Zhengzhou,
Hennan, China), (12 h light/dark cycle, 25°C and humidity 45 to 65%) and were fed with standard rodent diet and water ad libitum. All animal
procedures were approved by the ethical committee in accordance with the ‘Institute Ethical Committee Guidelines’ for animal experimentation
and care (HNPR-2009-05003). Animals were housed in polycarbonate cages.
Instruments
UV-2000 spectrophotometer (Unico Instrument Co., Ltd, Shanghai). Electronic balance (Mettler-Toledo Instrument Co., Ltd. USA),
Multiskan MK3 microplate reader (Thermo Instrument Co., Ltd. USA), 985370-395-type tissue machine (BIOSREC, Mexico).
Plant material
N nucifera leaves (Voucher number 20070815) were collected from Henan province in Augest 2007, and identified by Professor
Chang-qin Li (1.Institute of Chinese Meteria Medica, Henan University). The specimen was deposited in Institute of Chinese Meteria Medica,
Henan University.
The air dried Nelumbo nucifera leaves (3.25 kg) were extracted three times with acetone water solution (acetone:distilled water=7:3) for
7 days at room temperature. After evaporation of solvent in a vacuum, the concentrated extract was suspended in water and extract with
petroleum ether, EtOAC and n-BuOH, respectively. The solution was concentrated under reduced pressure to yield petroleum ether extract (55 g,
NUPE), EtOAC extract (81.5 g, NUEA) and n-BuOH extract (175 g, NUBU), respectively.
Antioxidant activity using DPPH assay
DPPH radical scavenging activity was assayed according to the method of Kang (Kang and Wang, 2010). 0.1 mL different extracts of
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NU in methanol had been mixed with 3.5 mL DPPH methanol solution (0.06 mmol/L). The solution was measured at 515 nm after 30 min at
room temperature with PG, BHA and BHT as positive control. The antioxidant activity was expressed as an IC50 value, that is the concentration in
μg/mL that scavenging DPPH· absorption by 50%, and was calculated from the concentration-effect linear regression curve.
Antioxidant activity using ABTS assay
Scavenging activity on ABTS radical of different extract of NU was evaluated in accordance with the literature (Li et al., 2011; Yue and
Kang et al., 2011). The different extracts (0.15 mL) were mixed with ABTS radical stock solution (2.85 mL). The absorbance was observed at 734
nm after incubated 10 min at 370C with PG, BHA and BHT as positive control. The Scavenging rate of ABTS·+ was calculated using the formula:
Scavenging rate (%) = [(A0-A1)/A0]×100, where A0 was the absorbance of the control and A1 was the absorbance of the sample and the standard
compound.
FRAP reducing activity assay
According to the literature (Li et al., 2011; Yue and Kang et al., 2011), the NU extracts (0.2 mL) and fresh prepared TPTZ stock solution
(3.8 mL) were mixed and incubated at 370C for 30 min. The absorbance was measured at 593 nm. Trolox was used as a reference standard. The
standard curve was linear between 25 and 400 μmol/L Trolox. Results were expressed in μmol Trolox equivalents (TEAC) (TE)/g sample. In this 
study, RACT50 was used to express Trolox equivalent (RACT50 = the concentration of Trolox cleared 50% free radical/ the concentration of
compound or condensate cleared 50% free radical).
Hepatoprotective effect in vivo
Ninety KM male mice (20±2 g) were randomly divided into nine groups of ten each. Group 1 (normal control) was treated with distilled
water. Group 2 (liver injury model control) was treated with distilled water. Group 3 was fed Dangfeiliganning capsule (1400 mg/kg) as positive
control. Group 4, 5 and 6 were given 523, 261.5 and 130.8 mg/kg of NUEA, respectively. Group 7, 8 and 9 were received 840.5, 420.5 and 210
mg/kg of NUBU, respectively. Administration adopted gastric lavage daily for 8 days. On the eighth day, except for the normal group, other
group animals were given a single dose of 0.1 ml/10 g b.w. CCl4 that was diluted with corn oil by intraperitoneally injection after 2 h of the last
administration. All groups were added to the drinking water but not feeding for 16 h. Blood was collected from mice eyeball for the levels of GPT
and GOT in serum. The liver was removed to prepare liver homogenate solution of 10% and 1% for determining the content of MDA and the
level of SOD by tissue homogenizer, respectively. The content of protein was determined by the method of Comassie brilliant blue G-250. The
levels of GPT, GOT and SOD and the content of MDA were determined by the requirements of kits.
Statistical analysis
All data were statistically evaluated with SPSS 17.0 software. Statistical comparisons were compared by one-way analysis of variance
(ANOVA). The results were considered statistically signiﬁcant if the p values were 0.05 or less. All results are expressed as mean ± standard
deviation (SD) for ten mice in each group.
Results
Assay for antioxidant activity in vitro
The antioxidant activity of the extracts with half inhibitory scavenging (IC50) and Trolox equivalent (RACT50) was shown in Table 1. In
DPPH assay, the DPPH radical scavenging activity of NUEA (IC50= 6.68±0.29 µg/mL) and NUBU (IC50= 4.61±0.01 µg/mL) were higher than
that of BHT (IC50= 8.76±0.20 µg/mL), and far higher than that of Dangfeiliganning (IC50= 28.06±0.17 µg/mL). The activity of NUBU was a bit
higher than that of NUEA. In ABTS assay, the ABTS radical scavenging activity of NUEA (IC50= 5.32±0.12 µg/mL) and NUBU (IC50=
8.16±0.27 µg/mL) were higher than that of Dangfeiliganning (IC50= 9.76±0.16 µg/mL), and far higher than that of NUPE (IC50= 78.51±0.20
µg/mL). The activity of NUEA was a bit higher than that of NUBU. In FARP assay, ferric reducing antioxidant power of NUEA
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(RACT50=1749.82±67.03 µmol/g) and NUBU (RACT50=1995.27±135.71 µmol/g) were higher than that of Dangfeiliganning
(RACT50=1028.55±3.28 µmol/g) and BHT (RACT50=1581.68±97.41 µmol/g), and far higher than that of NUPE (RACT50=405.82±17.03
µmol/g).
Table 1: Antioxidant activity of NU extracts by DPPH, ABTS and FRAP assay
Sample DPPH
IC50 (µg/mL)
ABTS
IC50 (µg/mL)
FRAP
RACT50(µmol/g)
NUPE 87.30±0.35 78.51±0.20 405.82±17.03
NUEA 6.68±0.29 5.32±0.12 1749.82±67.03Extracts
NUBU 4.61±0.01 8.16±0.27 1995.27±135.71
Capsule A Dangfeiliganning 28.06±0.17 9.76±0.16 1028.55±3.28
PG 0.61±0.01 0.91±0.02 11554.78±501.34
BHA 2.16±0.03 1.78±0.01 6633.04±114.04Positive ControlB
BHT 8.76±0.20 1.54±0.05 1581.68±97.41
A: Dangfeiliganning capsule is one of the Chinese patent drugs, not include adjuvant and can been detected in antioxidant capability.
B: Three positive Controls: Propyl gallate (PG), Butylated hydroxyanisole(BHA) and Butylated hydroxytoluene(BHT)are finest antioxidants,
have strong toxicity and often use in antioxidant experiments in vitro.
Hepatoprotective activity in vivo
Effect of NUEA and NUBU on the levels of GPT and GOT in serum
As shown in Table 2 and Fig.1, compared with blank of group, the levels of GPT and GOT were signiﬁcantly increased (p<0.001) in CCl4
group, which indicated CCl4-induced liver injury mice model was established successfully. Compared with CCl4 group, the levels of GPT and
GOT (p<0.01 and p<0.05, respectively) in high and middle doses of NUEA groups (523 mg/kg and 261.5 mg/kg) were signiﬁcantly decreased. 
The low dose of NUEA group (130.8 mg/kg) had no significantly increased (p>0.05). The levels of GPT and GOT (p<0.001 and p<0.01, p<0.05,
respectively) in three doses of NUBU groups were signiﬁcantly decreased.  
Table 2: Effect of NUEA and NUBU on GPT and GOT in acute liver injury mice
Group Dose (mg/kg) GPT (U/mL) GOT (U/mL)
Bank of group / 22.1254±4.4152 40.2149±7.5030
CCL4 / 3559.075±627.1114### 2664.282±785.5137###
Positive control+ CCL4 1400 753.0253±65.7084*** 747.3594±168.2491***
NUEA 523 1507.406±385.5916** 1466.785±251.5703**
NUEA 261.5 2064.593±708.8452* 1953.84±366.8895*
NUEA 130.8 3802.158±709.5235 2571.684±891.8134
NUBU 840.5 1420.032±547.3112*** 1206.779±338.4166***
NUBU 420.5 2507.503±1014.0085** 1717.310±360.2130*
NUBU 210 2736.965±811.1835* 2036.000±682.5499*
Data expressed as means ± s.d (n=10). Dangfeiliganning was as the positive control drug. Blank of group compared to CCL4-induced acute liver
injury: #P<0.05, ## P <0.01, ### P <0.001. Treated group compared to CCL4-induced acute liver injury:*P＜0.05, **P＜0.01, ***P＜0.001
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Figure 1: Effect of NUEA and NUBU on the level of GPT and GOT in serum.
As shown in Table 3, Fig.2 and Fig.3, compared with blank of group, the content of MDA in liver homogenate solution was
significantly increased in (p<0.001) and the level of SOD in liver homogenate solution was significantly decreased (p<0.001) liver injury control
mice, which indicated that CCl4 could cause oxidative stress in mice. Compared with CCl4 group, the content of MDA was significantly
decreased (p<0.01 and p<0.05, respectively) in high dose of NUEA group (523 mg/kg) and high and middle doses of NUBU groups (840.5 and
420.5 mg/kg, respectively), and the other treatment groups had no significantly increased (p>0.05). The levels of SOD in each treatment group
were significantly increased (p<0.001, p<0.01 and p<0.05, respectively).
Table 3: Effect of NUEA and NUBU on MDA and SOD in acute liver injury mice
Group Dose (mg/kg) MDA (nmol/mgprot) SOD (U/mgprot)
Bank of group / 1.9651±0.6129 451.8104±72.7875
CCL4 / 4.0995±0.9059### 94.4888±72.7875###
Positive control+ CCL4 1400 2.7324±1.1128** 444.9721±54.7451***
NUEA 523 1507.406±385.5916* 342.4347±79.9700***
NUEA 261.5 3.8997±1.2178 216.6239±97.0241**
NUEA 130.8 4.5278±1.6412 153.8693±47.9484*
NUBU 840.5 2.6186±0.7695** 502.1480±24.1769***
NUBU 420.5 3.1887±1.3394* 437.6063±174.6291***
NUBU 210 5.2201±1.9589 190.3006±41.4079**
Data expressed as means ± s.d (n=10). Dangfeiliganning was as the positive control drug. Blank of group compared to CCL4-induced acute liver
injury: #P<0.05, ## P <0.01, ### P <0.001. Treated group compared to CCL4-induced acute liver injury: *P＜0.05, **P＜0.01, ***P＜0.001.
Figure 2: Effect of NUEA and NUBU on the levels of MDA in liver tissue
Yuan et al., Afr J Tradit Complement Altern Med. (2014) 11(3):85-91
http://dx.doi.org/10.4314/ajtcam.v11i3.12
90
Discussion
It could be seen from the above analysis that NUEA and NUBU had certain scavenging DPPH and ABTS radical activity and ferric
reducing antioxidant power in vitro. Meanwhile, NUEA and NUBU could signiﬁcantly decrease the levels of GPT and GOT in serum, the content 
of MDA in liver homogenate solution and increase the level of SOD in liver homogenate solution in CCl4-induced liver injury mice model in vivo,
which indicated that NUEA and NUBU had hepatoprotective effects against oxidant injury. CCl4 was metabolized to CCl3- and Cl-by microsomal
cytochrome P450 system in liver cell, and produce trichloromethyl peroxy radical (·OOCCl3), ·OOCCl3 attacked unsaturated fatty acids of
phospholipids in the cell membrane, leading to lipid peroxidation in the liver cells and generated amount of free radicals ( Halliwell and
Gutteridge, 1997). Hepatocellular damage could lead to glutamic-pyruvic transaminase (GPT) and glutamic oxalacetic transaminase (GOT) to
penetrate into the blood, which caused the raise of GOT and GPT in the serum (Romero et al., 1998; Berry et al., 1992). At the same time, lipid
peroxidation could produce some free radicals including malondialdehyde (MDA).
Figure 3: Effect of NUEA and NUBU on the contents of SOD in liver tissue
Superoxide dismutase (SOD) was responsible for the detoxification of deleterious oxygen radicals (Sandesh et al., 2010). In the present
study, NUEA and NUBU could decrease the content of MDA, which indicated that lipid peroxidation was weaken and produced less free radicals.
Cell membrane was protected and prevent GPT and GOT in the endochylema to plunge into the serum, so the levels of GPT and GOT was
decreased in serum. In addition, a signiﬁcant increase in the level of SOD as a defense against the presence of oxygen free radicals, and reduced 
the damage of cells. So, antioxidant was one of hepatoprotective mechanism to decrease lipid peroxidation and oxidant stress for NU
hepatoprotective effects.
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